Kinsella Kevin J 4
4 · AKESIS PHARMACEUTICALS, INC. · Filed Sep 14, 2007
Insider Transaction Report
Form 4
AKESIS PHARMACEUTICALS, INC.AKES.OB
Kinsella Kevin J
Director10% Owner
Transactions
- Purchase
Common Stock
2007-09-13$0.67/sh+2,500$1,675→ 8,131,775 total(indirect: By Partnership) - Purchase
Common Stock
2007-09-12$0.55/sh+5,000$2,750→ 8,131,775 total(indirect: By Partnership) - Purchase
Common Stock
2007-09-13$0.65/sh+5,000$3,250→ 8,131,775 total(indirect: By Partnership)
Footnotes (2)
- [F1]Includes: (A) 5,297,500 shares of Common Stock (including the 22,500 shares of Common Stock acquired in connection with the reported transactions) held of record by Avalon Ventures VII, L.P. (see note 2 below); and (B) 2,834,275 shares of Common Stock held by Mr. Kinsella in a trust for which Mr. Kinsella is the trustee.
- [F2]All of the shares of Common Stock acquired in connection with the reported transactions were acquired of record by Avalon Ventures VII, L.P. Mr. Kinsella is the managing member of Avalon Ventures VII GP, LLC, which acts as the general partner of Avalon Ventures VII, L.P. As a result, Mr. Kinsella may be deemed to be the beneficial owner of the shares of Common Stock acquired in connection with the reported transactions. However, Mr. Kinsella disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.